Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Search

Page Path
HOME > Search
1 "Yutaka Nagata"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
Inflammatory bowel diseases
Risk of surgery in patients with stricturing type of Crohn’s disease at the initial diagnosis: a single center experience
Yuji Maehata, Yutaka Nagata, Tomohiko Moriyama, Yuichi Matsuno, Atsushi Hirano, Junji Umeno, Takehiro Torisu, Tatsuya Manabe, Takanari Kitazono, Motohiro Esaki
Intest Res 2019;17(3):357-364.   Published online February 21, 2019
DOI: https://doi.org/10.5217/ir.2018.00107
AbstractAbstract PDFPubReaderePub
Background/Aims
It remains uncertain which patients with stricturing-type Crohn’s disease (CD) require early small bowel surgery after the initial diagnosis. We aimed to clarify clinical characteristics associated with the intervention in such condition of CD.
Methods
We retrospectively evaluated the clinical course of 53 patients with CD and small bowel strictures who were initially treated with medications after the initial diagnosis. We investigated possible associations between small bowel surgery and the following: clinical factors and radiologic findings at initial diagnosis and the types of medications administered during follow-up.
Results
Twenty-eight patients (53%) required small bowel resection during a median follow-up period of 5.0 years (range, 0.5–14.3 years). The cumulative incidence rates of small bowel surgery at 2, 5, and 10 years were 26.4%, 41.0%, and 63.2%, respectively. Univariate analysis indicated that obstructive symptoms (P=0.036), long-segment stricture (P<0.0001), and prestenotic dilation (P<0.0001) on radiography were associated with small bowel surgery, and immunomodulatory (P=0.037) and biological therapy (P=0.008) were significant factors during follow-up. Multivariate analysis revealed that long-segment stricture (hazard ratio [HR], 4.25; 95% confidence interval [CI], 1.78–10.53; P=0.001) and prestenotic dilation (HR, 3.41; 95% CI, 1.24–9.62; P=0.018) on radiography showed a positive correlation with small bowel surgery, and biological therapy (HR, 0.40; 95% CI, 0.15–0.99; P=0.048) showed a negative correlation.
Conclusions
CD patients with long-segment stricture and prestenotic dilation on radiography seem to be at a higher risk of needing small bowel surgery. For such patients, early surgical intervention might be appropriate, even at initial diagnosis.

Citations

Citations to this article as recorded by  
  • Risk factors for stricture-related surgery in stricturing Crohn’s disease
    Emil Yunusov, Betul Piyade, Ilkay Ergenc, Muhammed Enes Tasci, Nisanur Sariyar, Yesim Ozen Alahdab, Ozlen Atug, Haluk Tarik Kani
    BMC Gastroenterology.2026;[Epub]     CrossRef
  • Colonic strictures in Crohn’s disease: a non-surgical survival
    Sarra Laabidi, Hamed Aboubecrine, Salma Souissi, Donia Gouiaa, Asma Labidi, Nadia Ben Mustapha, Anis Haddad, Amine Sebai, Meriem Serghini, Monia Fekih, Hanene Jaziri, Jalel Boubaker
    Future Science OA.2025;[Epub]     CrossRef
  • Crohn Disease Strictures: Multimodality Imaging to Identify Imaging Biomarkers
    Safa Hoodeshenas, Jonathan R. Dillman, Stuart A. Taylor, Jordi Rimola, Bachir Taouli, Kathryn A. Robinson, Aiming Lu, David J. Bartlett, David H. Bruining, Catherine E. Hagen, Ajit H. Goenka, Shigao Chen, Florian Rieder, Brian Feagan, Mark E. Baker, Joel
    RadioGraphics.2025;[Epub]     CrossRef
  • Comprehensive review and update of stricturing Crohn’s disease
    Alexander T. Elford, Zaid Ardalan, Paul Simkin, Britt Christensen
    Indian Journal of Gastroenterology.2024; 43(1): 64.     CrossRef
  • A global consensus on the definitions, diagnosis and management of fibrostenosing small bowel Crohn’s disease in clinical practice
    Dominik Bettenworth, Mark E. Baker, Joel G. Fletcher, Vipul Jairath, Cathy Lu, Willem Bemelman, Geert d’Haens, Andre d’Hoore, Axel Dignass, Iris Dotan, Roger Feakins, Phillip Fleshner, Christina Ha, Gaylyn Henderson, Ruishen Lyu, Julian Panes, Gerhard Rog
    Nature Reviews Gastroenterology & Hepatology.2024; 21(8): 572.     CrossRef
  • Reliability of MR Enterography Features for Describing Fibrostenosing Crohn Disease
    Florian Rieder, Mark E. Baker, David H. Bruining, Jeff L. Fidler, Eric C. Ehman, Shannon P. Sheedy, Jay P. Heiken, Justin M. Ream, David R. Holmes, Akitoshi Inoue, Payam Mohammadinejad, Yong S. Lee, Stuart A. Taylor, Jaap Stoker, Guangyong Zou, Zhongya Wa
    Radiology.2024;[Epub]     CrossRef
  • Reliability of CT Enterography for Describing Fibrostenosing Crohn Disease
    Florian Rieder, Christopher Ma, Jurij Hanzel, Joel G. Fletcher, Mark E. Baker, Zhongya Wang, Leonardo Guizzetti, Lisa M. Shackelton, Julie Rémillard, Mihir Patel, Jiafei Niu, Ronald Ottichilo, Cynthia S. Santillan, Nunzia Capozzi, Stuart A. Taylor, David
    Radiology.2024;[Epub]     CrossRef
  • Use of oral diet and nutrition support in management of stricturing and fistulizing Crohn's disease
    Kush Fansiwala, Neha D. Shah, Kelly A. McNulty, Mary R. Kwaan, Berkeley N. Limketkai
    Nutrition in Clinical Practice.2023; 38(6): 1282.     CrossRef
  • Sarcopenia hinders the decline in disease activity after surgery for people with Crohn's disease: Preliminary results
    Asuka Yasueda, Yuki Sekido, Takashi Takeda, Takayuki Ogino, Norikatsu Miyoshi, Hidekazu Takahashi, Mamoru Uemura, Yuichiro Doki, Hidetoshi Eguchi, Tsunekazu Mizushima
    Nutrition.2022; 94: 111526.     CrossRef
  • Efficacy of drug and endoscopic treatment of Crohn's disease strictures: A systematic review
    Julien D Schulberg, Emily K Wright, Bronte A Holt, Helen E Wilding, Amy L Hamilton, Alyson L Ross, Michael A Kamm
    Journal of Gastroenterology and Hepatology.2021; 36(2): 344.     CrossRef
  • Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease
    Yoon Suk Jung, Minkyung Han, Sohee Park, Jae Hee Cheon
    Gut and Liver.2021; 15(1): 92.     CrossRef
  • Molecular targets and the use of biologics in the management of small bowel fibrosis in inflammatory bowel disease
    Muaad Abdulla, Thean Soon Chew
    Current Opinion in Gastroenterology.2021; 37(3): 275.     CrossRef
  • Real world analysis on the efficacy and safety of anti-tumor necrosis factor therapy in patients with stricturing Crohn’s disease
    Sudheer K. Vuyyuru, Bhaskar Kante, Peeyush Kumar, Pabitra Sahu, Saurabh Kedia, Mukesh Kumar Ranjan, Raju Sharma, Rajesh Panwar, Govind Makharia, Vineet Ahuja
    Scientific Reports.2021;[Epub]     CrossRef
  • Inpatient Management of Inflammatory Bowel Disease-Related Complications
    Manreet Kaur, Robin L. Dalal, Seth Shaffer, David A. Schwartz, David T. Rubin
    Clinical Gastroenterology and Hepatology.2020; 18(6): 1346.     CrossRef
  • Surgical treatment of intestinal stricture in inflammatory bowel disease
    Helen M. Mohan, John C. Coffey
    Journal of Digestive Diseases.2020; 21(6): 355.     CrossRef
  • 9,680 View
  • 192 Download
  • 15 Web of Science
  • 15 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP